Financial Performance - Consolidated net sales for Q3 2024 were 42.9million,adecreaseof3.8 million, or 8.2%, compared to Q3 2023, primarily due to a 7.3% decrease in average selling prices and a 2.0% decrease in pounds shipped [93]. - For the first nine months of 2024, consolidated net sales were 137.2million,adecreaseof14.8 million, or 9.7%, driven by a 14.2% decrease in average selling prices, partially offset by a 3.0% increase in pounds shipped [94]. - Consolidated gross profit for Q3 2024 increased 116.5% to 6.5million,or15.13.0 million, or 6.4% of sales in Q3 2023 [95]. - Operating income for Q3 2024 was 0.5million,comparedtoanoperatinglossof15.1 million in Q3 2023, driven by increased gross profit and reduced prior year goodwill impairment [97]. - Specialty Chemicals segment net sales for Q3 2024 totaled 20.9million,anincreaseof0.8 million, or 4.1%, from Q3 2023, driven by a 6.1% increase in average selling prices [98]. - Tubular Products segment net sales for Q3 2024 totaled 22.0million,adecreaseof4.7 million, or 17.5%, primarily due to a 17.2% decrease in average selling prices [105]. Expenses and Income - SG&A expenses for Q3 2024 decreased to 6.0million,or14.06.7 million, or 14.3% of sales in Q3 2023 [97]. - Interest expense for Q3 2024 decreased to 0.1million,downfrom1.1 million in Q3 2023, primarily due to lower outstanding debt [113]. - Unallocated corporate expenses for Q3 2024 decreased by 1.4million,or46.21.6 million, or 3.7% of sales, compared to 3.0million,or6.42,397,000, compared to a loss of 13,097,000forthesameperiodin2023[118].−TheadjustedEBITDAfortheninemonthsendedSeptember30,2024,was1,446,000, a significant improvement from a loss of 9,993,000inthesameperiodof2023[118].−Thecompanyachievedanetincomeof367,000 in the specialty chemicals segment for the three months ended September 30, 2024, compared to a net loss of 11,498,000inthesameperiodof2023[119].−TubularproductssegmentreportedanEBITDAof2,327,000 for the three months ended September 30, 2024, compared to 156,000inthesameperiodof2023[120].CashFlowandLiquidity−CashprovidedbyoperatingactivitiesfortheninemonthsendedSeptember30,2024,was7,445,000, an increase from 4,002,000inthesameperiodof2023[123].−AsofSeptember30,2024,thecompanyheld8.5 million in cash and cash equivalents and had 57.5millionavailableonitsrevolvinglineofcredit[122].−Thecompanyexperiencedanetincreaseincashandcashequivalentsof5,486,000 for the nine months ended September 30, 2024, compared to a decrease of 17,842,000inthesameperiodof2023[123].−ThecompanyhadnodebtoutstandingunderitscreditfacilitiesasofSeptember30,2024[129].−ThecompanyisincompliancewithallfinancialdebtcovenantsasofSeptember30,2024[130].−Currentratioimprovedto3.8asofSeptember30,2024,comparedto3.7onDecember31,2023[135].−Operatingandfinanceleaseobligationstotaled33.3 million, with 1.7millionpayablewithinthenext12months[136].CapitalExpendituresandFinancialPosition−Capitalspendingisexpectedtobeasmuchas0.8 million for the remainder of fiscal 2024 [137]. - No off-balance sheet arrangements are expected to materially affect the company's financial position [137]. - There have been no significant changes in accounting policies or critical estimates since the end of fiscal 2023 [138]. - Return on average equity (ROAE) improved to (14.4)% as of September 30, 2024, from (38.6)% on December 31, 2023 [135]. - The company repurchased 42,623 shares at an average price of 9.79duringthethreemonthsendedSeptember30,2024,totaling418,563 [132].